MedTrace Logo

The Benefits of Early Initiation of Continual Renal Replacement Therapy in Patients With Severe Sepsis

NCT03141112 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2017-05-04

No results posted yet for this study

Summary

The study will evaluate the benefit of early initiation of CRRT in the initial phase of severe sepsis in patients admitted to the ICU. Primary evaluated end-point is 28-day mortality. Secondarily evaluated end-point is length of ICU-stay, length of stay in hospital, duration of mechanical ventilation. There are two groups. One group of participants with early CRRT initiation and another group with late CRRT initiation. Reference group no CRRT.

Conditions

  • Severe Sepsis

Interventions

PROCEDURE

renal replacement therapy

Sponsors & Collaborators

  • Radovan Uvizl

    lead OTHER

Principal Investigators

  • Radovan Uvizl · UH Olomouc, Czech Republic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-12-31
Completion
2020-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03141112 on ClinicalTrials.gov